Skip to content
OpenCapital
Get started

Revvity RVTY Life Sciences — Goodwill

Other segment segments

Diagnostics
$1.86B-4.0%

Similar metrics at other companies

Agilent Technologies logo
ALife Sciences and Diagnostics Markets — Goodwill
$3B-0.1%
Agilent Technologies logo
ALife Sciences and Applied Markets — Goodwill
$1.58B+0.3%
Donaldson Company logo
DCILife Sciences Segment — Goodwill
$172.8M+2.2%
WAT
WATBiosciences — Goodwill
$3.8B—
Donaldson Company logo
DCILife Sciences Segment — Goodwill acquired
$0—
PEA
PEAKLifescience — Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
——

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%—
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's life sciences — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's life sciences — goodwill?
Revvity (RVTY) reported life sciences — goodwill of $4.75B in Q1 2026.
How has Revvity's life sciences — goodwill changed year-over-year?
Revvity's life sciences — goodwill increased by 3.9% year-over-year, from $4.58B to $4.75B.
What does life sciences — goodwill mean?
The excess purchase price paid for acquired businesses within the Life Sciences segment.
How do you interpret life sciences — goodwill?
An increase suggests recent M&A activity, while a decrease may indicate impairment charges due to underperforming acquisitions.
How does life sciences — goodwill compare across companies?
Commonly reported by life science and diagnostic peers as part of segment-level intangible asset disclosures.